GPS shoes for Alzheimer's patients to hit US

2011-10-23T10:30:15Z

The first shoes with built-in GPS devices -- to help track down dementia-suffering seniors who wander off and get lost -- are set to hit the US market this month, the manufacturer says.

GTX Corp said the first batch of 3,000 pairs of shoes has been shipped to the footwear firm Aetrex Worldwide, two years after plans were announced to develop the product.

The shoes will sell at around $300 a pair and buyers...

Roche drug shows promise in early Alzheimer's

2011-10-10T15:30:16Z

(Reuters) - An experimental drug being developed by Roche Holding AG removed amyloid plaques from the brains of Alzheimer's disease patients in a small early-stage study, according to data published in the Archives of Neurology, the Swiss drugmaker said on Monday.

Many researchers suspect the build-up of such pla...

Insulin spray aided memory in Alzheimer's study

2011-09-12T13:30:10Z

CHICAGO (Reuters) - A daily spritz of insulin in the nose helped improve memory skills in people with Alzheimer's-linked memory problems, U.S. researchers said on Monday.

Patients in a small study -- who include people with mild to moderate Alzheimer's and a pre-Alzheimer's condition known as amnestic mild cognitive impairment, or aM...

Genetic Alzheimer's detectable 20 years before onset: study

2011-07-20T12:30:27Z

Inherited forms of Alzheimer's disease is likely detectable up to 20 years before loss of memory and impaired thinking appear, according to a study released Wednesday.

Measurable changes in brain chemistry show up years before these signature symptoms of the degenerative brain disease set in, researchers reported at the Alzheimer's Association International Conference in Paris.

Alzheimer's drug from Pfizer, J&J may prove safer

2011-07-20T10:00:13Z

PARIS (Reuters) - Experimental Alzheimer's drug bapineuzumab, from Pfizer and Johnson & Johnson , may be safer than originally thought, according to two studies by U.S. researchers released on Wednesday.

They said that a brain swelling condition called vasogenic edema, which caused a lot of worry over the drug's safety ea...

Special report: With Alzheimer's in the genes, when do you test?

2011-07-20T02:00:19Z

PARIS (Reuters) - As a boy, Gary Reiswig would take his grandfather by the hand and guide him on walks around the family farm in western Oklahoma. At 5, Gary knew to avoid the prairie dog town, fearful that his grandfather might stumble over one of the holes that the rodents burrowed into the grassy plain.

Occasionally...

Many fear Alzheimer's, want to be tested: survey

2011-07-19T23:00:06Z

PARIS (Reuters) - Alzheimer's is the second-most feared disease after cancer and many people say they would seek testing for themselves or a loved one even if they did not have symptoms, U.S. and European researchers said on Wednesday.

The findings, presented at the Alzheimer's Association Internationa...

Two antidepressants ineffective for dementia: study

2011-07-19T10:00:39Z

HONG KONG (Reuters) - Two antidepressants that are commonly given to Alzheimer's disease patients appear not only to be ineffective but may give side effects such as nausea and drowsiness, a study in Britain has found.

In a paper published in the medical journal The ...

Study finds two antidepressants ineffective for dementia

2011-07-19T04:00:11Z

In a paper published in the medical journal The ...

Falls, eye tests may hint at early Alzheimer's

2011-07-18T11:00:05Z

PARIS (Reuters) - People at risk for Alzheimer's are twice as likely to fall as healthy people, and the disease might also be visible in scans of the eye, researchers said on Sunday.

The preliminary results, presented at the Alzheimer's Association International Conference in Reuters) - Three patients treated with an experimental Bristol-Myers Squibb Alzheimer's drug have developed a type of brain swelling known as vasogenic edema, but the side effect may be common in Alzheimer's patients, researchers said on Monday.

Vasogenic edema may even be a sign that ...

U.S. autopsy guidelines revised for Alzheimer's

2011-07-17T11:30:18Z

PARIS (Reuters) - For many years, an autopsy done by a pathologist was considered the best way to confirm the presence of Alzheimer's disease.

But new guidelines proposed on Sunday by the U.S. National Institute on Aging and the Reuters) - People at risk for Alzheimer's are twice as likely to fall as healthy people, and the disease may also be visible in scans of the eye, researchers said on Sunday.

The studies, presented at the Alzheimer's Association International Conference in Pa...

Avid CEO confident in Alzheimer's imaging agent

2011-07-16T12:00:35Z

PARIS (Reuters) - The chief executive of Eli Lilly and Co's Alzheimer's imaging unit is confident it can create a training program for its imaging drug that will satisfy concerns raised by U.S. regulators.

So are many Alzheimer's disease experts, who are gathering in CHICAGO (Reuters) - Academic and industry experts said on Tuesday they have convinced U.S. regulators to ease safety restrictions imposed on clinical trials of Alzheimer's drugs, a move that could improve the chances that a drug being developed jointly by Pfizer and Johnson...

US country singer Glen Campbell has Alzheimer's

2011-06-23T03:30:19Z

US country music veteran Glen Campbell, famous for hits like "Rhinestone Cowboy," has Alzheimer's disease, the singer announced.

In an interview with People magazine, the 75-year-old and his wife Kim said they decided to go public because he plans a final series of concerts later this year and wants fans to know his condition.

"Glen is still an ...

Country star Glen Campbell says he has Alzheimer's

2011-06-22T13:30:56Z

LOS ANGELES (Reuters) - "Rhinestone Cowboy" singer Glen Campbell says he is in the early stages of Alzheimer's disease, and has recorded one last album as a farewell to his fans.

Campbell, 75, had been suffering from short-term memory loss for years, but the terminal Alzheimer's di...

Study finds way to get antibody therapies into brain

2011-05-25T18:00:06Z

CHICAGO (Reuters) - Scientists have found a way to get antibody-based therapies across a key barrier in the brain and deliver a payload of drugs that take aim at an elusive Alzheimer's target.

The researchers at Roche Holding AG's biotechnology unit

King features Ruvo Center

2011-05-12T02:30:40Z

Larry King highlighted Las Vegas' Cleveland Clinic Lou Ruvo Center for Brain Health during his first CNN special since retiring in December.

"Unthinkable: The Alzheimer's Epidemic," which aire...

Public Citizen: Key data left out of Alzheimer's study

2011-05-10T17:00:10Z

CHICAGO (Reuters) - A U.S. consumer group alleged on Tuesday that researchers with ties to Eli Lilly and Co withheld important information from a medical journal in their study of an imaging drug for Alzheimer's disease.

In a letter published in th...

Key data left out of Alzheimer's study: group

2011-05-10T15:00:07Z

CHICAGO (Reuters) - A consumer group alleged on Tuesday that researchers with ties to Eli Lilly and Co withheld important information from a medical journal in their study of an imaging drug for Alzheimer's disease.

In a letter published in the CHICAGO (Reuters) - Brain scans of healthy people showed signs that the brain was shrinking in Alzheimer's-affected areas nearly a decade before the disease was diagnosed, U.S. researchers said on Wednesday.

The finding, published in the journal Neurology, may offer a new way to detect the disease early, an advance that could help in...

Common drug ineffective in early Alzheimer's-study

2011-04-11T14:00:09Z

CHICAGO (Reuters) - A commonly prescribed Alzheimer's drug had no effect in treating patients with a mild form of the disease, U.S. researchers said on Monday, underscoring the need for new and better treatments for the most common form of dementia.

Sold under the brand US researchers said Thursday.

Scientists recreated the airborne pollutants that come from the burning of fossil fuels and the weathering of car parts and pavement, and exposed mice to the harsh air for 15 hours per week over 10 weeks.

The tiny air particles were "roughly one-thousandth the width of a human hai...

Study finds blood marker can't predict Alzheimer's

2011-04-05T13:30:18Z

LONDON (Reuters) - Scientists searching for clues to Alzheimer's have found that higher blood levels of a protein called clusterin are closely linked with the presence and severity of the brain disease, but not with the risk of developing it.

The research, published in the CHICAGO (Reuters) - Early studies suggest an experimental Alzheimer's drug attacks free-floating bits of a protein called beta amyloid, a sign the drug may fight what some researchers consider to be the disease's chief culprit.

Bapineuzumab, being developed by Pfizer Inc and Johns...

U.S. team makes key memory cells in lab dish

2011-03-03T22:30:06Z

CHICAGO (Reuters) - U.S. researchers have coaxed stem cells into becoming a type of brain cell that dies off early in people with Alzheimer's disease.

The new technology would provide a ready supply of cells for use in testing new drugs or even transplants to help restore lost memory, the ...

US expert panel gives nod to Alzheimer's scan

2011-01-21T16:30:18Z

An advisory committee to the US Food and Drug Administration has recommended a new brain scan procedure for detecting Alzheimer's disease, as long as doctors receive additional training to use it.

The process involves injecting a chemical called Amyvid, made by US pharmaceutical giant

UK cost agency to extend use of Alzheimer's drugs

2011-01-18T10:30:22Z

LONDON (Reuters) - Britain's health costs agency has confirmed a plan to end restrictions on the use by the National Health Service (NHS) of some Alzheimer's medicines, a change that should allow hundreds of thousands of new patients to get the drugs from March.

Around 750,000 people in Britain suffer from some form of ...

Ronald Reagan's son: Alzheimer's seen during presidency

2011-01-14T20:00:14Z

WASHINGTON (Reuters) - Former President Ronald Reagan, who was diagnosed with Alzheimer's disease five years after leaving office, showed signs of the condition while still in the White House, his son says in a new memoir.

In the book, "My Father at 100, a Memoir," Ron Reagan writes he had an inkling of t...

New blood test could detect Alzheimer's

2011-01-06T14:30:20Z

US scientists may have found a new way to use a blood test to search for clues of Alzheimer's disease, a discovery that if proven could extend to other ailments, said a study released Thursday.

"If this works in Alzheimer's disease, it suggests it is a pretty general platform that may work for a lot of different diseases," said Thomas Kodadek of The Scripps Research Institute<...

Alzheimer's researcher hit by car in Ohio, dies

2010-12-20T18:00:17Z

Alzheimer's disease researcher dies after being hit by car as he walked along roadway in Ohio

Police say a renowned Alzheimer's disease researcher has died after being hit by a car in Ohio, and the man suspected of hitting him also has been found dead.

Police say 45-year-old Mark A. Smith was struck early Sunday as he walked along a road in Bainbridge Township. Police say they found the car that hit Smith ...

Protein reversed memory loss in Alzheimer's mice

2010-12-13T12:30:15Z

CHICAGO (Reuters) - Boosting levels of a memory-related protein reversed memory loss in mice with Alzheimer's disease, a finding that could lead to new approaches to treating people, U.S. researchers said on Monday.

They said raising levels of CREB-binding protein (CBP) -- a protein needed to create long-term memories -- improved mem...

Walking May Reduce Cognitive Decline

2010-11-30T12:39:19Z

...

Moderate Drinking Linked to Lower Risk of Alzheimer's Disease

2010-11-29T15:01:56Z

...

Health Highlights: Nov. 29, 2010

2010-11-29T14:35:15Z

...

Nov. 29, 2010

2010-11-29T14:38:40Z

...

Chronic High Cholesterol Linked to Brain Damage

2010-11-29T14:40:01Z

...

Researchers ID Phenotype Tied to Maternal Alzheimer's History

2010-11-29T14:46:42Z

...

Exposing a Galaxy within the Brain

2010-11-29T14:46:32Z

...

2009 Rita Hayworth Alzheimer's Gala

2010-03-30T15:36:20Z

2009 Rita Hayworth Alzheimer's Gala Waldorf Astoria Hotel, New York City 10-27-2009 Photo By Judie Burstein-Globe Photos, Inc. 2009

Prevent Alzheimer's Disease